HomeHealth
Health
Express Scripts Comments on FTC’s Reckless Insulin Action
Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action
ST. LOUIS, Sept. 20, 2024 /PRNewswire/ -- Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today...
Satisfyer Announces Extensive Expansion to 6,700+ CVS Stores
Satisfyer has embarked on one of its most significant retail expansions to date through a strategic partnership with CVS.
NEW YORK, Sept. 20, 2024 /PRNewswire/ -- The leading brand in sex tech innovation, Satisfyer was established in 2016 when it set the tone with the launch...
Medical Solutions ranks among fastest-growing US staffing firms
Company continues to demonstrate growth and commitment to innovation and excellence
OMAHA, Neb., Sept. 20, 2024 /PRNewswire/ -- Medical Solutions has once again secured a place among SIA's Fastest-Growing US Staffing Firms for 2024. The company, which connects nurses and allied health clinicians with hospitals and...
American Pharmacists Association applauds FTC action on PBMs’ alleged inflation of insulin drug prices
WASHINGTON, Sept. 20, 2024 /PRNewswire/ -- Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, executive vice president and CEO of APhA, commended the Federal Trade Commission's (FTC) action today against alleged practices by large vertically integrated pharmacy benefit managers (PBMs) "for engaging in anticompetitive and unfair...
INSIGHTEC APPOINTS INDUSTRY LEADER JAKE GHANNAM AS CHIEF COMMERCIAL OFFICER USA – English Israel – English
HAIFA, Israel and MIAMI, Sept. 3, 2024 /PRNewswire/ -- Insightec, a global healthcare company dedicated to using focused ultrasound to transform patient care, today announced the appointment of Jake Ghannam as Chief Commercial Officer. In this new role, Ghannam will be responsible for leading...
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit
LOS ANGELES, Sept. 3, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against CVS Health Corporation ("CVS" or the "Company") (NYSE: CVS).Class Period: May 3, 2023 – April...
- Advertising -
- Advertising -
- Advertising -
- Advertising -